China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026)
China Pharma Holdings' (CPHI) quarterly EPS (Basic) came in at -$0.04 in Q1 2026, up 81.46% YoY from -$0.02 in Q1 2025, and up 84.32% on a QoQ basis from -$0.28 in Q4 2025.
China Pharma Holdings (CPHI) EPS (Basic) (2011 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 16 years of EPS (Basic) data on file, last reported at -$0.04 in Q1 2026.
- Quarterly EPS (Basic) rose 81.46% year-over-year to -$0.04 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.14 (up 90.11% YoY) and the FY2025 annual result came in at -$0.56, up 72.61% from the prior year.
- EPS (Basic) improved to -$0.04 in Q1 2026, from -$0.28 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.04 in Q1 2026 to a low of -$12.02 in Q4 2022.
- A 5-year average of -$3.31 and a median of -$0.89 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) declined 29.1% — and 2025, when it surged 81.84%.
- Tracing CPHI's EPS (Basic) over 5 years: stood at -$12.02 in 2022, then soared by 69.71% to -$3.64 in 2023, then jumped by 80.75% to -$0.7 in 2024, then soared by 59.38% to -$0.28 in 2025, then jumped by 84.32% to -$0.04 in 2026.
- The last three EPS (Basic) figures came in at -$0.04 (Q1 2026), -$0.28 (Q4 2025), and -$0.17 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.04 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.17 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.70 |
| Sep 30, 2024 | -0.65 |
| Jun 30, 2024 | -0.89 |
| Mar 31, 2024 | -0.73 |
| Dec 31, 2023 | -3.64 |
| Sep 30, 2023 | -2.94 |
| Jun 30, 2023 | -2.99 |
| Mar 31, 2023 | -2.95 |
| Dec 31, 2022 | -12.02 |
| Sep 30, 2022 | -7.91 |
| Jun 30, 2022 | -9.16 |
| Mar 31, 2022 | -10.87 |
| Dec 31, 2021 | -10.63 |
| Sep 30, 2021 | -8.99 |
| Jun 30, 2021 | -9.05 |